Paper Details 
Original Abstract of the Article :
Diclofenac is a well established nonsteroidal anti-inflammatory drug (NSAID) used in the treatment of a variety of painful inflammatory conditions. Although generally well tolerated, diclofenac, like other NSAIDs, is associated with gastrointestinal adverse effects which infrequently can be serious ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.2165/00002512-199507050-00005

データ提供:米国国立医学図書館(NLM)

Diclofenac/Misoprostol: A Solution for Pain and Ulcer Prevention

The field of pain management is constantly striving to find effective and safe treatments for patients with painful inflammatory conditions. This review examines the pharmacology and therapeutic efficacy of the fixed combination of diclofenac, a non-steroidal anti-inflammatory drug (NSAID), and misoprostol, a prostaglandin E1 analogue, for managing these conditions. The authors highlight the potential of this combination to provide pain relief while reducing the risk of NSAID-induced gastrointestinal ulcers.

Diclofenac/Misoprostol: A Balancing Act

This review showcases the potential benefits of the diclofenac/misoprostol combination for managing painful inflammatory conditions. The authors note that this combination provides comparable pain relief to other NSAIDs, while significantly reducing the risk of gastrointestinal ulcers. This makes it a valuable option for patients who require NSAID therapy but are at increased risk for ulcer complications.

A Balancing Act: Pain Relief and Ulcer Prevention

This research highlights the importance of finding a balance between pain relief and minimizing adverse effects. The diclofenac/misoprostol combination offers a promising approach for managing painful inflammatory conditions, particularly for patients at risk for NSAID-induced ulcers. It's a reminder that effective pain management requires a careful assessment of individual patient needs and a commitment to maximizing benefit while minimizing risk.

Dr. Camel's Conclusion

This research is like finding a cool, refreshing spring in the middle of a scorching desert. It's a reminder that effective pain management requires a careful balance between relief and safety. The diclofenac/misoprostol combination offers a valuable tool for navigating this complex landscape.

Date :
  1. Date Completed 1996-03-12
  2. Date Revised 2018-11-13
Further Info :

Pubmed ID

8573992

DOI: Digital Object Identifier

10.2165/00002512-199507050-00005

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.